Studies from several laboratories suggest that oxidized LDL may play an important role in atherogenesis. Our group previously showed that treatment of aortic endothelial cells with low levels of MM-LDL caused increased expression of MCP-1, M-CSF, tissue factor, and a monocyte-binding protein. In these studies MM-LDL was produced by storage of native LDL. We now show that cocultures of endothelial and smooth muscle cells can also produce MM-LDL from native LDL. This production of MM-LDL by cells is prevented by preincubating the LDL with probucol or vitamin E. However, addition of antioxidants to MM-LDL did not block its action. In past studies we also showed that endothelial cells exhibit differential sensitivity to the effects of MM-LDL. We report herein that in resistant cells there is no elevation of catalase, glutathione peroxidase, or copper-zinc-dependent SOD. However, maganese-dependent SOD is elevated in resistant cells. Ways in which MM-LDL production may be elevated in poorly controlled diabetics subjects are discussed.
Skip Nav Destination
Article navigation
Articles|
October 01 1992
Minimally Modified Lipoproteins in Diabetes
JA Berliner;
JA Berliner
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
M Territo;
M Territo
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
M Navab;
M Navab
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
A Andalibi;
A Andalibi
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
F Parhami;
F Parhami
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
F Liao;
F Liao
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
J Kim;
J Kim
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
S Estworthy;
S Estworthy
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
AJ Lusis;
AJ Lusis
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
AM Fogelman
AM Fogelman
Departments of Pathology and Medicine, University of California
Los Angeles; and City of Hope, Duarte, California
Search for other works by this author on:
Address correspondence and reprint requests to J.A. Berliner, PhD, Department of Pathology, University of California, Los Angeles, CA 90024
Diabetes 1992;41(Supplement_2):74–76
Article history
Received:
April 03 1992
Accepted:
May 12 1992
PubMed:
1526340
Citation
JA Berliner, M Territo, M Navab, A Andalibi, F Parhami, F Liao, J Kim, S Estworthy, AJ Lusis, AM Fogelman; Minimally Modified Lipoproteins in Diabetes. Diabetes 1 October 1992; 41 (Supplement_2): 74–76. https://doi.org/10.2337/diab.41.2.S74
Download citation file: